NCT05858996 · Phase 2 · RECRUITING
Testing the Pain Clinical Practice Guideline
This trial is testing a structured pain management program for nursing home residents who have dementia. Half of the participating homes will get the full program, which includes monthly team meetings, staff training, mentoring, and ongoing tracking of resident pain. The other half gets staff education only. Researchers want to see whether the full program reduces pain intensity over 12 months. This is a Phase 2 trial, meaning it is testing effectiveness, not yet a proven standard of care.
You may qualify if
- Living in a participating community
- 60 years of age or older
- Evidence of dementia based on a score of 0-12 on the Brief Interview of Mental Status (BIMS); a score of >2 on the AD8 Dementia Screening Interview; a score of 0.5 to 2.0 on the Clinical Dementia Rating Scale (CDR); and lastly to differentiate between dementia and mild cognitive impairment a score of 9 or greater on the Functional Activities Questionnaire (FAQ).
- have evidence of pain at the time of recruitment based on the Minimum Data set assessment item: How much of the time over the past 5 days have you experienced pain or hurting with eligibility based on the following responses or evidence: occasionally, frequently or almost constantly, or staff report of pain at the same frequency; or if the resident is receiving nonpharmacological or pharmacological treatment for pain.
You're excluded if
- admitted to the nursing home for short-stay rehabilitation or other subacute needs (e.g., intravenous antibiotics);
- receiving Hospice care.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-05-08